Kreafarma SRL
Kreafarma reported total assets of €2.09m at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Kreafarma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +101 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Kreafarma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 16 Jul 2025
- Year ended 31 Dec 2023filed on 27 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Kreafarma's financial analysis
- Solvency27.3%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Kreafarma
Kreafarma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0684.714.981
- VAT number
- BE0684714981
- Peppol
- Registered · 0208:0684714981 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Nov 2017
- Registered office
- 2020 Antwerp
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Kreafarma (SRL) has been based in Antwerp since 2017, active in: activities of holding companies. For 2025, it reports a net profit of 119,082 € and equity of 571,616 €; its revenue is not published. Its solvency stands at 27.3%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Kreafarma
Companies in the same business, of comparable size and area, outside its group.
- Johan Degroote & Cie Invest Activities of holding companies Wingene · balance sheet €2.09m
- Esqon Activities of holding companies Aalst · balance sheet €2.09m
- At Group Activities of holding companies Tessenderlo-Ham · balance sheet €2.09m
- Invado Activities of holding companies Nieuwpoort · balance sheet €2.09m
- CBV Holding Activities of holding companies Lokeren · balance sheet €2.10m
- Squirrel Activities of holding companies Tournai · balance sheet €2.09m
- Added Lights Activities of holding companies Antwerp · balance sheet €2.09m
- Bassengeholding Activities of holding companies Bassenge · balance sheet €2.09m
Frequently asked questions about Kreafarma
What is the revenue of Kreafarma?
Kreafarma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Kreafarma?
In Belgium, the VAT number is the company number prefixed with BE: BE0684714981 for Kreafarma, if the company is VAT-registered. Its company number (CBE) is 0684.714.981.
Where is the registered office of Kreafarma?
According to the CBE register, the registered office of Kreafarma is in 2020 Antwerp.
What is the equity of Kreafarma?
At the close of the 2025 financial year, the equity of Kreafarma amounts to 571,616 €, a solvency of 27.3% of total assets.
Who manages Kreafarma?
The register lists 2 active mandates at Kreafarma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Kreafarma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →